Biomerica Inc.

5.37+0.0500+0.94%Vol 51.56K1Y Perf -28.55%
Apr 9th, 2021 16:00 DELAYED
BID5.11 ASK5.39
Open5.36 Previous Close5.32
Pre-Market- After-Market-
 - -  - -%
Target Price
10.83 
Analyst Rating
Strong Buy 1.00
Potential %
101.68 
Finscreener Ranking
★★★★+     56.44
Insiders Trans % 3/6/12 mo.
-/100/-85 
Value Ranking
★★     48.31
Insiders Value % 3/6/12 mo.
-/100/-53 
Growth Ranking
★★★     53.43
Insiders Shares Cnt. % 3/6/12 mo.
-/100/-37 
Income Ranking
 —    -
Market Cap63.26M 
Earnings Rating
Neutral
Price Range Ratio 52W %
11.51 
Earnings Date
13th Apr 2021

Today's Price Range

5.205.41

52W Range

4.4112.75

5 Year PE Ratio Range

-20.90-16.90

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-8.83%
1 Month
-11.97%
3 Months
0.75%
6 Months
-31.59%
1 Year
-28.55%
3 Years
29.40%
5 Years
275.52%
10 Years
1 018.75%

TickerPriceChg.Chg.%
BMRA5.370.05000.94
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Financial StrengthValueIndustryS&P 500US Markets
3.90
6.40
0.12
0.15
-1 115 040.00
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
23.20
-69.50
-64.00
-24.00
-69.09
RevenueValueIndustryS&P 500US Markets
5.24M
0.44
1.16
2.13
Earnings HistoryEstimateReportedSurprise %
Q02 2021-0.10-0.13-30.00
Q01 2021-0.09-0.14-55.56
Q04 2020-0.06-0.0433.33
Q03 2020-0.07-0.09-28.57
Q02 2020-0.08-0.0537.50
Q01 2020-0.06-0.0516.67
Q04 2019-0.08-0.080.00
Q03 2019-0.05-0.07-40.00
Earnings Per EndEstimateRevision %Trend
2/2021 QR-0.02--
5/2021 QR-0.03-200.00Negative
5/2021 FY-0.35-16.67Negative
5/2022 FY0.09-80.00Negative
Next Report Date13th Apr 2021
Estimated EPS Next Report-0.02
Estimates Count2
EPS Growth Next 5 Years %25.00
Volume Overview
Volume51.56K
Shares Outstanding11.78M
Trades Count353
Dollar Volume338.59K
Avg. Volume385.99K
Avg. Weekly Volume358.23K
Avg. Monthly Volume137.39K
Avg. Quarterly Volume406.40K

Biomerica Inc. (NASDAQ: BMRA) stock closed at 5.37 per share at the end of the most recent trading day (a 0.94% change compared to the prior day closing price) with a volume of 52.29K shares and market capitalization of 63.26M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 45 people. Biomerica Inc. CEO is Zackary S. Irani.

The one-year performance of Biomerica Inc. stock is -28.55%, while year-to-date (YTD) performance is 7.83%. BMRA stock has a five-year performance of 275.52%. Its 52-week range is between 4.41 and 12.75, which gives BMRA stock a 52-week price range ratio of 11.51%

Biomerica Inc. currently has a PE ratio of -14.70, a price-to-book (PB) ratio of 5.78, a price-to-sale (PS) ratio of 12.75, a price to cashflow ratio of 99.50, a PEG ratio of 2.32, a ROA of -41.66%, a ROC of -50.28% and a ROE of -61.83%. The company’s profit margin is -69.09%, its EBITDA margin is -64.00%, and its revenue ttm is $5.24 Million , which makes it $0.44 revenue per share.

Of the last four earnings reports from Biomerica Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.02 for the next earnings report. Biomerica Inc.’s next earnings report date is 13th Apr 2021.

The consensus rating of Wall Street analysts for Biomerica Inc. is Strong Buy (1), with a target price of $10.83, which is +101.68% compared to the current price. The earnings rating for Biomerica Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Biomerica Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Biomerica Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 21.31, ATR14 : 0.50, CCI20 : -87.44, Chaikin Money Flow : -0.19, MACD : -0.30, Money Flow Index : 22.47, ROC : -11.96, RSI : 40.74, STOCH (14,3) : 30.21, STOCH RSI : 0.87, UO : 38.97, Williams %R : -69.79), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Biomerica Inc. in the last 12-months were: Catherine Coste (Buy at a value of $49 595), Mark A. Sirgo (Sold 20 000 shares of value $161 755 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. Majority of the company's revenue is earned from the Europe market.

CEO: Zackary S. Irani

Telephone: +1 949 645-2111

Address: 17571 Von Karman Avenue, Irvine 92614, CA, US

Number of employees: 45

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

71%29%

Bearish Bullish

55%45%

Bearish Bullish

58%42%

News

Stocktwits